» Articles » PMID: 37714849

Divergent Single Cell Transcriptome and Epigenome Alterations in ALS and FTD Patients with C9orf72 Mutation

Abstract

A repeat expansion in the C9orf72 (C9) gene is the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here we investigate single nucleus transcriptomics (snRNA-seq) and epigenomics (snATAC-seq) in postmortem motor and frontal cortices from C9-ALS, C9-FTD, and control donors. C9-ALS donors present pervasive alterations of gene expression with concordant changes in chromatin accessibility and histone modifications. The greatest alterations occur in upper and deep layer excitatory neurons, as well as in astrocytes. In neurons, the changes imply an increase in proteostasis, metabolism, and protein expression pathways, alongside a decrease in neuronal function. In astrocytes, the alterations suggest activation and structural remodeling. Conversely, C9-FTD donors have fewer high-quality neuronal nuclei in the frontal cortex and numerous gene expression changes in glial cells. These findings highlight a context-dependent molecular disruption in C9-ALS and C9-FTD, indicating unique effects across cell types, brain regions, and diseases.

Citing Articles

Epigenetic regulation of iron metabolism and ferroptosis in Parkinson's disease: Identifying novel epigenetic targets.

Gao X, Ding J, Xie J, Xu H Acta Pharmacol Sin. 2025; .

PMID: 40069488 DOI: 10.1038/s41401-025-01499-6.


pTDP-43 levels correlate with cell type-specific molecular alterations in the prefrontal cortex of ALS/FTD patients.

Wang H, Xiang J, Yuan C, Veire A, Gendron T, Murray M Proc Natl Acad Sci U S A. 2025; 122(9):e2419818122.

PMID: 39999167 PMC: 11892677. DOI: 10.1073/pnas.2419818122.


Whole-genome bisulfite sequencing of cell-free DNA unveils age-dependent and ALS-associated methylation alterations.

Jin Y, Conneely K, Ma W, Naviaux R, Siddique T, Allen E Cell Biosci. 2025; 15(1):26.

PMID: 39980027 PMC: 11843967. DOI: 10.1186/s13578-025-01366-1.


The Promise of Epigenetic Editing for Treating Brain Disorders.

Gonzalez Molina L, Dolga A, Rots M, Sarno F Subcell Biochem. 2025; 108():111-190.

PMID: 39820862 DOI: 10.1007/978-3-031-75980-2_4.


Epigenetics in Neurodegenerative Diseases.

van Zundert B, Montecino M Subcell Biochem. 2025; 108():73-109.

PMID: 39820861 DOI: 10.1007/978-3-031-75980-2_3.


References
1.
Freibaum B, Lu Y, Lopez-Gonzalez R, Kim N, Almeida S, Lee K . GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015; 525(7567):129-33. PMC: 4631399. DOI: 10.1038/nature14974. View

2.
Mariga A, Mitre M, Chao M . Consequences of brain-derived neurotrophic factor withdrawal in CNS neurons and implications in disease. Neurobiol Dis. 2016; 97(Pt B):73-79. PMC: 5295364. DOI: 10.1016/j.nbd.2016.03.009. View

3.
Li J, Jaiswal M, Chien J, Kozlenkov A, Jung J, Zhou P . Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation. Nat Commun. 2023; 14(1):5714. PMC: 10504300. DOI: 10.1038/s41467-023-41033-y. View

4.
Renton A, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs J . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011; 72(2):257-68. PMC: 3200438. DOI: 10.1016/j.neuron.2011.09.010. View

5.
Khakh B, Sofroniew M . Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci. 2015; 18(7):942-52. PMC: 5258184. DOI: 10.1038/nn.4043. View